Thomas Keeble and Marko Noc tackle the tricky question of how to deal with a patient with out-of-hospital cardiac arrest.

While STEMI patients should almost invariably go directly to the cathlab, the situation seems less clear-cut for non-ST-elevation patients, for whom a genuinely personalized approach needs to be proposed.

Study...

What areas are most subject to drug-coated balloon angioplasty in de novo lesions? Fernando Alfonso and Robert Byrne provide some answers in this interview, in which they list the scenarios in which this technology appears attractive.

Small vessel disease, diffuse disease, STEMI, side-branches and patients at high-bleeding risk are...

What is the evidence for the need for PCI in patients with stable coronary artery disease and severe aortic stenosis? Is invasive angiography always mandatory for these patients? What about CT scans? When exactly should PCI be performed?

These are the questions Vijay Kunadian and Martine Gilard...

Tune in for an enlightening interview with Julie Tyler, President of Abbott's Vascular Business, in which she talks about the company's involvement in EuroPCR 2023.

Discover how EuroPCR provides a platform for training, collaboration, and advancements in the vascular field, perfectly aligning with Abbott's goal of reimagining...

Listen to the interview with Bernard Zovighian, Chief Executive Officer, who explains Edwards Lifesciences' involvement in the 2023 edition of EuroPCR.

Involved in a number of studies on mitral, tricuspid and aortic valves, he insists on the BENCHMARK late-breaking trial, which shows that, with streamlined TAVR procedures,...

What is the optimal TAVI access approach in today’s practice? Ole De Backer and Maarten Vanhaverbeke break down the latest evidence and trends in TAVI access. Watch this video to learn about the dominance of transfemoral access, the role of alternative routes like transcarotid and transaxillary,...

What does it take to ensure a smooth, safe, and confident discharge for TAVI patients? Sarah Carson and Gemma McCalmont share valuable insights and practical strategies. From pre-assessment planning and early mobilization to managing complications and preparing patients for recovery, this video offers essential tips for...

In this video, Jens Flensted Lassen and Thomas Cuisset discuss the importance of the side branch during bifurcation percutaneous coronary intervention (PCI). They emphasize that while there is no perfect solution for all patients, decisions must be tailored to each individual case, often influenced by the patient's...

Access this discussion between Douglas Fraser, Lars Søndergaard & Stefan Toggweiler in which they explain what the cusp overlap technique is and how it can be used to ensure sustained outcomes for the patient. Also watch this video to get insights on how commissural alignment can help with...

Heinz Joachim Büttner (Germany) shares his experience as a chronic total occlusion (CTO) operator with Francesco Della Rosa (Italy) as they discuss why there has been so much focus on chronic total occlusion interventions at EuroPCR 2019. After reviewing the various sessions, Dr Büttner explains the...

Despite guidelines that recommend the use of physiological assessment in coronary artery disease, it is only used in less than 10% of cases. Join Emanuele Barbato and Carlos Collet as they look at some of the reasons behind this low rate of implementation. They describe a...

Spyros Linardos (Greece) and Ricardo Esteves (Portugal) discuss the importance of training in developing a safe and effective CTO programme. This can only be possible with the support of the hospital directors and the help of role models. In this very long intervention, every member of...

Nicolas Dumonteil (France) and Maurizio Taramasso (Switzerland) talk about the relatively recent development of tricuspid interventions. Clinical and anatomical selection criteria for these high-risk patients are considered, and a comprehensive overview of multimodal imaging and devices is provided. The therapeutic options for reducing TR and improving...

Patrick Calvert (UK) explains to Dejan Milasinovic (Serbia) how his centre has set up a protocol to treat high-risk NSTEMI patients with the aim of achieving the guideline recommended time of 24 hours from presentation to Cathlab. They discuss the design of the system and what...

Hannah McConkey (UK) talks to cardiologist and pharmacologist Atul Pathak (France) about the important changes in recent drug therapy. They discuss the easy-to-use lipid-lowering PCSK9 inhibitors, and ask should cardiologists now be prescribing the new classes of antidiabetic drugs? The key messages in antithrombotic therapy, and how to...

Martine Gilard (France), Philip MacCarthy (UK) and Michael Lee (Hong Kong) discuss what’s new at EuroPCR 2019 to meet the demands of a rapidly expanding population: simplifying the technique and minimising the risk to the patient, acknowledging the huge expansion of mitral edge-to-edge repair and the...

Lynne Hinterbuchner (Germany) talks with Gerda Donnelly (Germany) about educating nurses and allied professions about newly introduced technology for the treatment of mitral insufficiency. They discuss the best preparation for nurses, the importance of the Heart Team as a whole to become familiar with the new...

PCROnline Editor Davide Capodanno raises the hot topic of how to manage antithrombotic therapy in patients with atrial fibrillation who need dual antiplatelet therapy.  He asks Dominick Angiolillo from the USA for practical advice about which anticoagulants and P2Y12 inhibitors to use, and the most difficult...

Michael HAUDE discusses left main trifurcation PCI with Alaide CHIEFFO from Italy, and Darius DUDEK from Poland. They bring their experience of treating this challenging lesion subset to talk about the broad spectrum of techniques required in the interventionalist’s toolbox, the available technologies and the use...

In this short video, Bernado Cortese (Italy) describes the interim analysis of the Eastbourne study, which is evaluating the performance of a sirolimus-eluting DCB for the treatment of any type of coronary lesion, including native vessel disease and in-stent restenosis. The Eastbourne registry is enrolling patients...